Skip to content
Lower risk Drug recall · FDA · Published October 11, 2022

LNK Walgreens Sinus Relief Product Mislabeled as Decongestant-Free

Walgreens sinus relief product labeled 'Decongestant Free' contains phenylephrine nasal decongestant. Recalled due to mislabeling.

🇺🇸 FDA recall #D-0014-2023DrugLNK International ›
Take action

Contact the company

Recalling firmLNK International, Inc.55 Arkay Dr · Hauppauge, NY 11788-3707
✎ GovInfoNow plain-language explainer

Walgreens sinus pressure and cough relief products labeled as 'Decongestant Free' actually contain phenylephrine nasal decongestant. This mislabeling could cause unintended decongestant effects for people who shouldn't use decongestants. Read more at govinfonow.com/recall/34267-lnk-walgreens-sinus-relief-product-mislabeled-as-decongestant-free.

Source Summary by GovInfoNow · govinfonow.com/recall/34267-lnk-walgreens-sinus-relief-product-mislabeled-as-decongestant-free · Updated August 18, 2026 · FDA enforcement record: FDA #D-0014-2023

Cite this page

“LNK Walgreens Sinus Relief Product Mislabeled as Decongestant-Free.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34267-lnk-walgreens-sinus-relief-product-mislabeled-as-decongestant-free. Based on FDA recall #D-0014-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0014-2023%22&limit=1).

The FDA announced on Oct. 11, 2022, that LNK International, Inc. is recalling NDC 0363-6171-09 Walgreens Sinus Pressure, Pain & Cough because boxes are mislabeled as "Decongestant Free" despite containing Phenylephrine HCl. According to the FDA, consumers should stop using the product and return it for a refund.

How to tell if you have it

  • Brand: LNK International
  • Product: Walgreens Sinus Pressure, Pain & Cough ACETAMINOPHEN/ PAIN RELIEVER DEXTROMETHORPHAN HBr/ COUGH SUPPRESSANT GUAIFENESIN/ EXPECTORANT PHENYLEPHRINE HCl/ NASAL DECONGESTANT Maximum Strength
  • NDC: 0363-6171-09
  • Lot codes: P129910, P129911, P130240
  • Quantity: 66,384 boxes of twenty tablets each

The hazard

The product boxes are mislabeled to read "Decongestant Free," but the product contains Phenylephrine HCl 5mg. This labeling error poses a risk to consumers who must avoid decongestants.

Context

GovInfoNow's records show LNK International, Inc. has had five other recalls on record since July 18, 2012. Other recent recalls of similar products include Kirkland Severe Cold & Flu Recall (Nov. 14, 2024) and LNK Nighttime Sleep-Aid Tablets Recall (Aug. 4, 2022). Similar recent recalls include Nephron Albuterol Inhaler (March 17, 2026) and Walgreens Saline Nasal Spray with Xylitol Recall (Nov. 12, 2025).

How to tell if you have this one

Check for the product labeled 'Decongestant Free' at Walgreens stores. The NDC code 0363-6171-09 identifies this specific product.

  • Brand
    LNK International
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the label that says 'Decongestant Free' on the product packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Oct 11, 202212. FDA classified it Class III: Oct 18, 202223. Published in FDA’s Enforcement Report: Oct 26, 202234. FDA terminated the recall: Jul 25, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0014-2023 (October 11, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0014-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA